Posted 05 February, 2024
Alto Neuroscience, Inc. IPO completed
IPO completed detected for ticker NYSE:ANRO in a 424B4 filed on 05 February, 2024.
This is our initial public offering, and prior to this offering there has been no public market for our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Alto Neuroscience, Inc.
Health Care/Life Sciences • Biotechnology
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Los Altos, CA.Market Cap
$333M
View Company Details
$333M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.